ABSTRACT The synthesis of cholesteryl esters in cultured human fibroblasts is catalyzed by a microsomal acyl-coenzyme A:cholesterol acyltransferase (EC 2.3.1.26 
with fibroblast monolayers at a concentration of 1 sg/ml, SC-31769 suppressed the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase [mevalonate:NADP+ oxidoreductase (CoA-acylating); EC 1.1.1.34], the rate-controlling enzyme in cholesterol synthesis. In contrast, progesterone had no effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity at concentrations as high as 25 ,ug/ml. The availability of two types of steroid compounds that inhibit the acyltransferase activity and cholesteryl ester synthesis in human fibroblasts should prove useful in further studies of the regulatory mechanisms responsible for cholesteryl ester accumu ation in human cells under normal and pathologic conditions. When cultured human fibroblasts are presented with an amount of cholesterol that exceeds that which can be incorporated into cellular membranes, the cells develop enhanced activity of an acyl-coenzyme A:cholesterol acyltransferase (acyltransferase; EC 2.3.1.26) (1) . This microsomal enzyme esterifies the excess cholesterol with long-chain fatty acids, and the resultant cholesteryl esters are stored in the cytoplasm as neutral lipid droplets (1, 2) . Acyltransferase can be stimulated in fibroblasts by incubation of the cells with cholesterol dissolved in ethanol or with cholesterol contained in low density lipoprotein (LDL), the major cholesterol transport protein in human plasma (1, 3) . In fibroblasts, the cholesterol-mediated stimulation of acyltransferase occurs in concert with a suppression of the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase [HMG CoA reductase; mevalonate: NADP+ oxidoreductase (CoA-acylating); EC 1.1.1.34] the rate-controlling enzyme in cholesterol biosynthesis (4) (5) (6) (7) . The reciprocal regulation of these two microsomal enzymes prevents an overaccumulation of free cholesterol and leads to an accumulation of cholesteryl esters when cells are exposed to LDL (1, 3) .
Interest in the acyltransferase reaction has been heightened by the awareness that this enzyme plays an important role in the accumulation of cholesteryl esters within smooth muscle cells of the artery wall during the development of atherosclerosis (1, 8, 9) . Recently, a group of steroids has been described that mimics the actions of cholesterol in activating the acyltransferase (5) and suppressing HMG CoA reductase (10) (11) (12) in cultured cells. These steroids, which are polar derivatives of cholesterol, include 7-ketocholesterol, 25-hydroxycholesterol, and 6-ketocholestanol. Stimulation of the acyltransferase by these steroids causes the cells to esterify a fraction of their own endogenous cholesterol. As a result, these steroids produce an increase in the cholesteryl ester content of fibroblasts even though they suppress cholesterol synthesis within the cell (5) .
In the current studies, we describe two steroids that differ from the previously described group of steroids in that both inhibit the synthesis of cholesteryl esters in intact fibroblasts by inhibiting the acyltransferase. One of these steroids, SC-31769, an analogue of 7-ketocholesterol, retains the ability to suppress HMG CoA reductase activity. The other steroid, progesterone, fails to suppress HMG CoA reductase activity. The inhibition of the acyltransferase by both steroids reduces the cellular accumulation of cholesteryl esters when fibroblasts are exposed to LDL. METHODS Steroids and Isotopes. SC-31769 (7-keto-20-oxacholesterol), SC-31448 (22-hydroxy-25-methylcholesterol), and SC-31082 (23,25-dihydroxy-23-methyl-21-norcholesterol) were synthesized at Searle Laboratories by procedures to be described elsewhere (unpublished data). The 3-oleate ester of SC-31769 was prepared by treatment of the steroid with oleoyl chloride in pyridine at room temperature for 18 hr, followed by purification on silica gel. Cholesterol was purchased from Applied Science, Inc. All other steroids were obtained from Steraloids, Inc. Each steroid was >98% pure, as judged by gas liquid and thin-layer chromatography. Solutions were prepared just prior to use by dissolving the steroid in ethanol or acetone. ["4ClOleate (58 mCi/mmol) was purchased from Amersham/Searle. [1-14C] Oleoyl CoA (55 mCi/mmol) and 3-hydroxy-3-methyl- [3-14C] glutaryl CoA (26.2 mCi/mmol) were obtained from New England Nuclear Corp. Tissue culture supplies and reagents for assays were obtained from previously described sources (11) .
Lipoproteins. LDL (density, 1.019-1.063 g/ml) and lipo- protein-deficient serum (density > 1.215 g/ml) were obtained from human plasma and prepared by differential ultracentrifugation (7) . The concentration of LDL is expressed in terms of its protein content. 125I-Labeled LDL (125I-LDL) was prepared as described (13) .
Cells. Fibroblasts from a healthy subject were grown in monolayer (11 Other Assays. The proteolytic degradation of 125I-LDL by intact fibroblasts was measured as described (14) . The gas-liquid chromatography (15) . The content of protein was determined by the method of Lowry et al. (16), with bovine serum albumin as a standard. Fig. 1 shows the structure of SC-31769, a 20-oxa analogue of 7-ketocholesterol. SC-31769 was nearly as potent as 25-hydroxycholesterol in suppressing HMG CoA reductase activity in human fibroblasts. At concentrations below 5 ,tg/ml, both steroids reduced this enzyme activity by more than 95% within 6 hr ( Fig. 2A) . However, whereas 25-hydroxycholesterol markedly stimulated the rate of [14C]oleate incorporation into cholesteryl esters, SC-31769 had much less effect (Fig. 2B) . We have previously shown that 7-ketocholesterol behaves similarly to 25-hydroxycholesterol in stimulating cholesteryl ester formation and in suppressing HMG CoA reductase activity in fibroblasts (5). The results in Fig. 2 therefore indicate that the modification of the 7-ketocholesterol side-chain in SC-31769 reduced the ability of this sterol to stimulate cholesteryl ester formation, but did not affect its ability to suppress HMG CoA reductase activity.
RESULTS
The failure of SC-31769 to maximally stimulate cholesteryl ester formation raised the possibility that the compound was actually an inhibitor of cholesterol esterification. Accordingly, we tested SC-31769 for its ability to inhibit the enhanced cholesteryl [14C]oleate formation that occurs in intact fibroblasts incubated with 25-hydroxycholesterol (4, 5) . At a concentration of 5 ,ug/ml, SC-31769 inhibited [14C]oleate incorporation into cholesteryl [14C]oleate by 90% when this incorporation had been stimulated by the addition of 25-hydroxycholesterol (Fig. 3) .
In addition to inhibiting cholesteryl ester formation in intact cells, SC-31769 inhibited the activity of the acyltransferase in cell-free homogenates of fibroblasts (Fig. 4A) . Neither cholesterol nor 25-hydroxycholesterol inhibited this enzyme (Fig.  4A ). The addition of large amounts of exogenous cholesterol to the in vitro enzyme assay system did not reverse the inhibitory effect of SC-31769 on the acyltransferase (Fig. 4B) When LDL is added to fibroblasts, the cellular content of free and esterified cholesterol increases (15) . The latter increase results from a lysosomal hydrolysis of the cholesteryl esters contained within LDL followed by a reesterification of the liberated cholesterol by the microsomal acyltransferase (3). Inasmuch as SC-31769 inhibited the acyltransferase, the steroid reduced the accumulation of esterified cholesterol that otherwise occurred when fibroblasts were exposed to LDL ( Table  2 ). The reduction in the cellular content of cholesteryl esters was balanced by an increase in the content of free cholesterol in the cells exposed to LDL in the presence of SC-31769. These data indicate that the total uptake and hydrolysis of LDLcholesteryl esters was unaffected by the compound and that the inhibition of cholesterol reesterification produced a disproportionate increase in the free cholesterol content of the cell. This conclusion was further supported by the finding that SC-31769 did not inhibit the cellular uptake and lysosomal degradation of 125I-LDL (Table 2) .
In view of the observation by Flint et al. that progesterone inhibited acyltransferase activity in extracts of interstitial tissue of the rabbit ovary (17) , it was of interest to study the effect of progesterone in the fibroblast system. Fig. 5 shows that at 7 the cells were divided into two groups. In one group, the medium was replaced with 2 ml ofgrowth medium containing 5,ul of ethanol and the indicated amount of either SC-31769 or LDL, or both.
After incubation for 15 hr at 370, the cells were harvested for measurement of their content of free and esterified cholesterol. Each value is the average of duplicate samples (three dishes per sample). In the second group of cells, the medium was replaced with 2 ml of growth medium containing 5% lipoprotein-deficient serum, 5,l of ethanol, 25 ug of 125I-LDL per ml (39,000 cpm/Mg), and either no SC-31769 or 5gg of SC-31769 per ml. After incubation for 15 hr at 370, the amount of l25-Ilabeled trichloroacetic acid-soluble (non-iodide) material formed by the cells and released into the medium was measured as described in Methods. Each value is the average of duplicate incubations. concentrations in the range of 10,ug/ml, progesterone caused a marked inhibition of LDL-mediated cholesteryl ester formation in intact cells and of acyltransferase activity in cell-free extracts. In striking contrast to SC-31769, progesterone at concentrations up to 25,g/ml caused no suppression of HMG CoA reductase activity in intact cells (Fig. 6) . 
